Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10143-10150
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Table 3 Major adverse cardiovascular events rate in patients with different GRACE risk scores receiving different treatments, n (%)
GRACE risk scores (points)
n
Medication group
Stent group
CABG group
Overall MACE rate
Hc value
P value
n
MACE rate
n
MACE rate
n
MACE rate
Low risk group (0-88)95654 (6.2)257 (28.0)52 (40.0)13 (13.7)5.2310.041
Intermediate risk group (89-117)1517122 (31.0)6620 (30.3)146 (42.9)48 (31.8)2.7420.086
High risk group (≥ 118)1405910 (16.9)6530 (46.2)167 (43.8)47 (33.6)5.3810.040
Total38619536 (18.5)15657 (36.5)3515 (42.9)108 (28.0)4.4120.044